Noninvasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 12, 2009, Pages 1960-1967

  Backes, Heiko ^a   Ullrich, Roland ^a   Neumaier, Bernd ^a   Kracht, Lutz ^a   Wienhard, Klaus ^a   Jacobs, Andreas H ^a,b  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^b KLINIKUM FULDA   (Germany)

Author keywords

18F FLT; Kinetic modelling; PET; Quantification

Indexed keywords

3' FLUOROTHYMIDINE F 18; KI 67 ANTIGEN; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; 3' FLUOROTHYMIDINE; DIAGNOSTIC AGENT;

ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; GLIOMA; HUMAN; HUMAN TISSUE; METABOLIC RATE; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; ARTERY; BIOLOGICAL MODEL; BRAIN; BRAIN TUMOR; CELL PROLIFERATION; KINETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SCINTISCANNING; VASCULARIZATION;

ARTERIES; BRAIN; BRAIN NEOPLASMS; CELL PROLIFERATION; DIDEOXYNUCLEOSIDES; GLIOMA; HUMANS; KINETICS; MODELS, BIOLOGICAL; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 71849098039     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1244-4     Document Type: Article

References (27)

1. LF de Geus-Oei EP Visser PF Krabbe BA van Hoorn EB Koenders AT Willemsen, et al. 2006 Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies J Nucl Med 47 945 949 16741303
2. SS Gambhir M Schwaiger SC Huang J Krivokapich HR Schelbert CA Nienaber, et al. 1989 Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose J Nucl Med 30 359 366 1:CAS:528:DyaK3cXmt1OhtL4%3D 2786939
3. G Germano BC Chen SC Huang SS Gambhir EJ Hoffman ME Phelps 1992 Use of the abdominal aorta for arterial input function determination in hepatic and renal PET studies J Nucl Med 33 613 620 1:STN:280:DyaK383gtlSisA%3D%3D 1552350
4. LA Green SS Gambhir A Srinivasan PK Banerjee CK Hoh SR Cherry, et al. 1998 Noninvasive methods for quantitating blood time-activity curves from mouse PET images obtained with fluorine-18-fluorodeoxyglucose J Nucl Med 39 729 734 1:CAS:528:DyaK1cXis1GisLk%3D 9544690
5. MC Kreissl HM Wu DB Stout W Ladno TH Schindler X Zhang, et al. 2006 Noninvasive measurement of cardiovascular function in mice with high-temporal-resolution small-animal PET J Nucl Med 47 974 980 16741307
6. LM Wahl MC Asselin C Nahmias 1999 Regions of interest in the venous sinuses as input functions for quantitative PET J Nucl Med 40 1666 1675 1:STN:280:DyaK1MvkvFSitQ%3D%3D 10520707
7. IN Weinberg SC Huang EJ Hoffman L Araujo C Nienaber M Grover-McKay, et al. 1988 Validation of PET-acquired input functions for cardiac studies J Nucl Med 29 241 247 1:STN:280:DyaL1c7lsFSgtQ%3D%3D 3258026
8. SH Yee PA Jerabek PT Fox 2005 Non-invasive quantification of cerebral blood flow for rats by microPET imaging of 15O labelled water: the application of a cardiac time-activity curve for the tracer arterial input function Nucl Med Commun 26 903 911 10.1097/00006231-200510000-00009 16160650 (Pubitemid 41426553)
9. PT Meyer V Circiumaru CA Cardi DH Thomas H Bal PD Acton 2006 Simplified quantification of small animal [18F]FDG PET studies using a standard arterial input function Eur J Nucl Med Mol Imaging 33 948 954 10.1007/s00259-006-0121-7 16699768 (Pubitemid 44127445)
10. S Takikawa V Dhawan P Spetsieris W Robeson T Chaly R Dahl, et al. 1993 Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve Radiology 188 131 136 1:STN:280:DyaK3s3ovVylsg%3D%3D 8511286
11. H Guo RA Renaut K Chen 2007 An input function estimation method for FDG-PET human brain studies Nucl Med Biol 34 483 492 10.1016/j.nucmedbio.2007. 03.008 1:CAS:528:DC%2BD2sXmvV2itL0%3D 17591548 (Pubitemid 46963013)
12. C Schiepers W Chen M Dahlbom T Cloughesy CK Hoh SC Huang 2007 18F-fluorothymidine kinetics of malignant brain tumors Eur J Nucl Med Mol Imaging 34 1003 1011 10.1007/s00259-006-0354-5 1:CAS:528:DC%2BD2sXmtl2jt7c%3D 17295039 (Pubitemid 46919556)
13. JR Grierson JL Schwartz M Muzi R Jordan KA Krohn 2004 Metabolism of 3′-deoxy-3′-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography Nucl Med Biol 31 829 837 10.1016/j.nucmedbio.2004.06.004 1:CAS:528:DC%2BD2cXotFCmu7Y%3D 15464384 (Pubitemid 39297680)
14. G Weber M Nagai Y Natsumeda S Ichikawa H Nakamura JN Eble, et al. 1991 Regulation of de novo and salvage pathways in chemotherapy Adv Enzyme Regul 31 45 67 10.1016/0065-2571(91)90008-A 1:CAS:528:DyaK38Xlt1ertrk%3D 1877399
15. H Barthel MC Cleij DR Collingridge OC Hutchinson S Osman Q He, et al. 2003 3′-deoxy-3′-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography Cancer Res 63 3791 3798 1:CAS:528:DC%2BD3sXltVGqs78%3D 12839975
16. AH Jacobs A Thomas LW Kracht H Li C Dittmar G Garlip, et al. 2005 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors J Nucl Med 46 1948 1958 1:CAS:528:DC%2BD28XivVSktA%3D%3D 16330557
17. AF Shields JR Grierson BM Dohmen HJ Machulla JC Stayanoff JM Lawhorn-Crews, et al. 1998 Imaging proliferation in vivo with [F-18]FLT and positron emission tomography Nat Med 4 1334 1336 10.1038/3337 1:CAS:528:DyaK1cXntlaqsrk%3D 9809561 (Pubitemid 28512118)
18. AK Buck H Schirrmeister M Hetzel M Von Der Heide G Halter G Glatting, et al. 2002 3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules Cancer Res 62 3331 3334 1:CAS:528:DC%2BD38XkslWqs7k%3D 12067968
19. KA Krohn DA Mankoff M Muzi JM Link AM Spence 2005 True tracers: comparing FDG with glucose and FLT with thymidine Nucl Med Biol 32 663 671 10.1016/j.nucmedbio.2005.04.004 1:CAS:528:DC%2BD2MXhtFKhsLfJ 16243640 (Pubitemid 41502970)
20. R Ullrich H Backes H Li L Kracht H Miletic K Kesper, et al. 2008 Glioma proliferation as assessed by 3′-fluoro-3′-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma Clin Cancer Res 14 2049 2055 10.1158/1078-0432.CCR-07-1553 1:CAS:528: DC%2BD1cXkt1akurY%3D 18381944 (Pubitemid 351551115)
21. M Muzi DA Mankoff JR Grierson JM Wells H Vesselle KA Krohn 2005 Kinetic modeling of 3′-deoxy-3′-fluorothymidine in somatic tumors: mathematical studies J Nucl Med 46 371 380 1:CAS:528:DC%2BD2MXit1CqurY%3D 15695799
22. M Muzi H Vesselle JR Grierson DA Mankoff RA Schmidt L Peterson, et al. 2005 Kinetic analysis of 3′-deoxy-3′-fluorothymidine PET studies: validation studies in patients with lung cancer J Nucl Med 46 274 282 1:CAS:528:DC%2BD2MXit1CqtbY%3D 15695787
23. EA McGuire JH Helderman JD Tobin R Andres M Berman 1976 Effects of arterial versus venous sampling on analysis of glucose kinetics in man J Appl Physiol 41 565 573 1:CAS:528:DyaE2sXhsVCjsg%3D%3D 985402
24. NN Abumrad D Rabin MP Diamond WW Lacy 1981 Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man Metabolism 30 936 940 10.1016/0026-0495(81)90074-3 1:CAS:528:DyaL3MXlsVKmu7w%3D 7022111 (Pubitemid 11057495)
25. D Visvikis D Francis R Mulligan DC Costa I Croasdale SK Luthra, et al. 2004 Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer Eur J Nucl Med Mol Imaging 31 169 178 10.1007/s00259-003- 1339-2 1:STN:280:DC%2BD2c3jtVGmuw%3D%3D 15129698 (Pubitemid 38173691)
26. AF Shields DA Briston S Chandupatla KA Douglas J Lawhorn-Crews JM Collins, et al. 2005 A simplified analysis of [18F]3′-deoxy-3′- fluorothymidine metabolism and retention Eur J Nucl Med Mol Imaging 32 1269 1275 1:CAS:528:DC%2BD2MXht1Skt73O 15991018
27. K Herholz J Rudolf WD Heiss 1992 FDG transport and phosphorylation in human gliomas measured with dynamic PET J Neurooncol 12 159 165 10.1007/BF00172667 1:STN:280:DyaK383hvV2ktA%3D%3D 1560262